750 likes | 781 Views
This article provides in-depth insights into the role of EGFR as a therapeutic target in head and neck squamous cell carcinoma (HNSCC). It explores the molecular mechanisms underlying EGFR signaling, its impact on HNSCC pathogenesis, and the latest advancements in targeted therapy strategies.
E N D